Rallybio Corp 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Rallybio Corp on August 26, 2025, regarding a change in its stock listing status. The company is incorporated in Delaware and trades under the symbol RLYB.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
- Listing Transfer: Due to failure to meet the minimum $1.00 closing bid price requirement by the August 25, 2025 deadline, the company's listing was transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market effective August 29, 2025.
- Compliance Extension: Nasdaq granted an additional 180-day compliance period, extending the deadline to February 23, 2026, to regain the minimum bid price requirement.
Outlook, Risks, and Management Commentary
Management intends to monitor the closing bid price and explore options to regain compliance, including the potential execution of a reverse stock split. The primary risk identified is potential delisting if the company fails to meet the minimum bid price requirement by the Second Compliance Date of February 23, 2026. In such an event, the company may appeal the determination to a Nasdaq Hearings Panel.
Investor Verification Checklist
- Verify the current trading status and bid price of RLYB on the Nasdaq Capital Market.
- Monitor future announcements regarding the potential implementation of a reverse stock split.
- Review the company's cash position in subsequent filings to assess its ability to fund operations while addressing the listing deficiency.
- Confirm the exact deadline for the Second Compliance Date (February 23, 2026) to avoid delisting.